{
 "PrintNo":"A5218","Session":2023,"Chamber":"ASSEMBLY","BillType":"Assembly","Published":"2023-03-07T12:20:31.183461Z",
 "Status":"IN_ASSEMBLY_COMM","Committee":"Health",
 "Milestones":[{"Type":"IN_ASSEMBLY_COMM","Date":"2024-01-03","Committee":"Health"}],
 "Actions":[
  {"Text":"REFERRED TO HEALTH","Date":"2023-03-07","Chamber":"ASSEMBLY"},
  {"Text":"REFERRED TO HEALTH","Date":"2024-01-03","Chamber":"ASSEMBLY"}
 ],
 "Sponsors":[
  {"ID":574,"Name":"William A. Barclay","Short":"BARCLAY"},{"ID":1251,"Name":"Brian Manktelow","Short":"MANKTELOW"},
  {"ID":1483,"Name":"John Lemondes","Short":"LEMONDES"},{"ID":1238,"Name":"Joe DeStefano","Short":"DESTEFANO"},
  {"ID":599,"Name":"Joseph Giglio","Short":"GIGLIO JM"},{"ID":631,"Name":"Kenneth Blankenbush","Short":"BLANKENBUSH"}
 ],
 "Title":"Relates to designating an individual to be notified in the case of dose or brand change for psychotropic medication",
 "Summary":"Designates an individual to be notified in the case of dose or brand change for psychotropic medication.",
 "LawSection":"Public Health Law","LawCode":"Amd ยง2803-c, Pub Health L",
 "ActClause":"AN ACT to amend the public health law, in relation to designating an individual to be notified in the case of dose or brand change for psychotropic medication",
 "PreviousVersions":["A8932-2019","A6628-2021"]
}